Waldron LP Invests $200,000 in PerkinElmer, Inc. (PKI) Stock

Waldron LP bought a new position in shares of PerkinElmer, Inc. (NYSE:PKI) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 2,900 shares of the medical research company’s stock, valued at approximately $200,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Vanguard Group Inc. increased its holdings in PerkinElmer by 2.6% during the second quarter. Vanguard Group Inc. now owns 10,886,642 shares of the medical research company’s stock worth $741,816,000 after buying an additional 273,975 shares during the last quarter. Janus Henderson Group PLC acquired a new position in PerkinElmer during the second quarter worth $436,483,000. BlackRock Inc. increased its holdings in PerkinElmer by 2.4% during the second quarter. BlackRock Inc. now owns 5,929,277 shares of the medical research company’s stock worth $404,022,000 after buying an additional 141,650 shares during the last quarter. Pictet Asset Management Ltd. increased its holdings in PerkinElmer by 2.1% during the second quarter. Pictet Asset Management Ltd. now owns 3,433,659 shares of the medical research company’s stock worth $216,526,000 after buying an additional 71,540 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its holdings in PerkinElmer by 9.9% during the third quarter. Ameriprise Financial Inc. now owns 955,790 shares of the medical research company’s stock worth $65,923,000 after buying an additional 86,395 shares during the last quarter. Institutional investors and hedge funds own 91.54% of the company’s stock.

Shares of PerkinElmer, Inc. (NYSE PKI) traded up $0.01 during trading on Friday, hitting $72.31. 611,665 shares of the stock were exchanged, compared to its average volume of 641,797. The company has a market capitalization of $7,970.37, a PE ratio of 26.01, a PEG ratio of 2.04 and a beta of 0.77. PerkinElmer, Inc. has a 52 week low of $49.72 and a 52 week high of $73.05. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.09 and a current ratio of 2.59.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Stockholders of record on Friday, January 19th will be given a $0.07 dividend. The ex-dividend date of this dividend is Thursday, January 18th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.39%. PerkinElmer’s payout ratio is presently 7.78%.

COPYRIGHT VIOLATION NOTICE: “Waldron LP Invests $200,000 in PerkinElmer, Inc. (PKI) Stock” was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this news story on another publication, it was stolen and reposted in violation of United States & international copyright laws. The original version of this news story can be accessed at https://sportsperspectives.com/2017/11/19/waldron-lp-invests-200000-in-perkinelmer-inc-pki-stock.html.

Several equities analysts have commented on the stock. Piper Jaffray Companies reiterated a “buy” rating and issued a $81.00 price objective on shares of PerkinElmer in a report on Friday, August 4th. BidaskClub downgraded shares of PerkinElmer from a “buy” rating to a “hold” rating in a report on Friday, July 28th. Citigroup Inc. reiterated a “buy” rating and issued a $80.00 price objective (up from $74.00) on shares of PerkinElmer in a report on Tuesday, September 26th. Zacks Investment Research downgraded shares of PerkinElmer from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Finally, Cowen and Company reiterated a “hold” rating and issued a $70.00 price objective on shares of PerkinElmer in a report on Friday, September 1st. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and six have issued a buy rating to the company. PerkinElmer has an average rating of “Hold” and a consensus target price of $68.64.

In other news, Director Peter Barrett sold 7,071 shares of the business’s stock in a transaction dated Monday, November 13th. The shares were sold at an average price of $71.07, for a total value of $502,535.97. Following the completion of the sale, the director now owns 26,271 shares of the company’s stock, valued at $1,867,079.97. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Nicholas A. Lopardo sold 24,050 shares of the business’s stock in a transaction dated Tuesday, November 7th. The shares were sold at an average price of $70.72, for a total transaction of $1,700,816.00. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

PerkinElmer Company Profile

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.

Want to see what other hedge funds are holding PKI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PerkinElmer, Inc. (NYSE:PKI).

Institutional Ownership by Quarter for PerkinElmer (NYSE:PKI)

Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply